by nick | Apr 2, 2024 | news
Cancer – a disease characterized by the uncontrolled growth and spread of abnormal cells in the body is a leading cause of death worldwide. The impact of cancer on society is multifaceted and profound and affects millions of individuals and their families every...
by Kenjiro Lolling | Oct 27, 2023 | news
Transvaal Pharmacy Strengthens Leading Position in the Field of Personalized Medicine with the NewDoseRx1 Drug Printer from Doser. Transvaal Apotheek, a pioneer in pharmacy compounding and tailored medicine, proudly announces deployment of the DoseRx1, agroundbreaking...
by Kenjiro Lolling | Oct 17, 2023 | news
There’s a distinction between merely attending a convention and capturing the undivided attention of its attendees. Last week, Doser achieved the latter at CES Unveiled! Doser was among the distinguished exhibitors at CES Unveiled, a prelude to the renowned...
by Kenjiro Lolling | Jun 29, 2023 | news
We’re thrilled to provide some electrifying updates from the heart of our operations – Doser Lab! Our exploration into the enthralling realm of 3D printing for pharmaceuticals continues, and we’re constantly unearthing new methodologies for...
by Kenjiro Lolling | Mar 27, 2023 | news
The Kansen voor West 3 “3D MedPrint” project aims to demonstrate the application of 3D printing at diverse user locations in the areas of 3D printing small tablets for children and printing multiple drugs in one tablet. The subsidy was granted to Doser and...
by Kenjiro Lolling | Mar 24, 2023 | news
We’re delighted to announce that Doser Medical has successfully passed the Factory Acceptance Test (FAT) for our innovative 3D compounding system at the Leiden University Medical Center (LUMC). The FAT, a key milestone in quality control and assurance, confirms...
